Table of Contents

1 Study Coverage

• 1.1 Glucokinase Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Glucokinase Market Size Growth Rate by Product
  • 1.4.2 LY-2608204
  • 1.4.3 Sinogliatin
  • 1.4.4 AM-9514
  • 1.4.5 TMG-123
  • 1.4.6 TTP-399
  • 1.4.7 Others
• 1.5 Market by End User
  • 1.5.1 Global Glucokinase Market Size Growth Rate by End User
  • 1.5.2 Metabolic Disorder
  • 1.5.3 Obesity
  • 1.5.4 Diabetes
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Glucokinase Market Size
  • 2.1.1 Global Glucokinase Revenue 2014-2025
  • 2.1.2 Global Glucokinase Sales 2014-2025
• 2.2 Glucokinase Growth Rate by Regions
  • 2.2.1 Global Glucokinase Sales by Regions
  • 2.2.2 Global Glucokinase Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Glucokinase Sales by Manufacturers
  • 3.1.1 Glucokinase Sales by Manufacturers
  • 3.1.2 Glucokinase Sales Market Share by Manufacturers
  • 3.1.3 Global Glucokinase Market Concentration Ratio (CR5 and HHI)
• 3.2 Glucokinase Revenue by Manufacturers
  • 3.2.1 Glucokinase Revenue by Manufacturers (2014-2019)
  • 3.2.2 Glucokinase Revenue Share by Manufacturers (2014-2019)
• 3.3 Glucokinase Price by Manufacturers
• 3.4 Glucokinase Manufacturing Base Distribution, Product Types
  • 3.4.1 Glucokinase Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Glucokinase Product Type
  • 3.4.3 Date of International Manufacturers Enter into Glucokinase Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Glucokinase Sales by Product
• 4.2 Global Glucokinase Revenue by Product
• 4.3 Glucokinase Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Glucokinase Breakdown Data by End User

6 North America

• 6.1 North America Glucokinase by Countries
  • 6.1.1 North America Glucokinase Sales by Countries
  • 6.1.2 North America Glucokinase Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Glucokinase by Product
• 6.3 North America Glucokinase by End User

7 Europe

• 7.1 Europe Glucokinase by Countries
  • 7.1.1 Europe Glucokinase Sales by Countries
  • 7.1.2 Europe Glucokinase Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Glucokinase by Product
• 7.3 Europe Glucokinase by End User

8 Asia Pacific

• 8.1 Asia Pacific Glucokinase by Countries
  • 8.1.1 Asia Pacific Glucokinase Sales by Countries
  • 8.1.2 Asia Pacific Glucokinase Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Glucokinase by Product
• 8.3 Asia Pacific Glucokinase by End User

9 Central & South America

• 9.1 Central & South America Glucokinase by Countries
  • 9.1.1 Central & South America Glucokinase Sales by Countries
  • 9.1.2 Central & South America Glucokinase Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Glucokinase by Product
• 9.3 Central & South America Glucokinase by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Glucokinase by Countries
  • 10.1.1 Middle East and Africa Glucokinase Sales by Countries
  • 10.1.2 Middle East and Africa Glucokinase Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Glucokinase by Product
• 10.3 Middle East and Africa Glucokinase by End User

11 Company Profiles

• 11.1 Amgen Inc
  • 11.1.1 Amgen Inc Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Amgen Inc Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Amgen Inc Glucokinase Products Offered
  • 11.1.5 Amgen Inc Recent Development
• 11.2 Eli Lilly and Co
  • 11.2.1 Eli Lilly and Co Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Eli Lilly and Co Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Eli Lilly and Co Glucokinase Products Offered
  • 11.2.5 Eli Lilly and Co Recent Development
• 11.3 Ligand Pharmaceuticals Inc
  • 11.3.1 Ligand Pharmaceuticals Inc Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Ligand Pharmaceuticals Inc Glucokinase Products Offered
  • 11.3.5 Ligand Pharmaceuticals Inc Recent Development
• 11.4 Merck & Co Inc
  • 11.4.1 Merck & Co Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Merck & Co Inc Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Merck & Co Inc Glucokinase Products Offered
  • 11.4.5 Merck & Co Inc Recent Development
• 11.5 Poxel SA
  • 11.5.1 Poxel SA Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Poxel SA Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Poxel SA Glucokinase Products Offered
  • 11.5.5 Poxel SA Recent Development
• 11.6 Teijin Pharma Ltd
  • 11.6.1 Teijin Pharma Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Teijin Pharma Ltd Glucokinase Products Offered
  • 11.6.5 Teijin Pharma Ltd Recent Development
• 11.7 vTv Therapeutics Inc
  • 11.7.1 vTv Therapeutics Inc Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 vTv Therapeutics Inc Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 vTv Therapeutics Inc Glucokinase Products Offered
  • 11.7.5 vTv Therapeutics Inc Recent Development
• 11.8 Yuhan Corp
  • 11.8.1 Yuhan Corp Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Yuhan Corp Glucokinase Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Yuhan Corp Glucokinase Products Offered
  • 11.8.5 Yuhan Corp Recent Development

12 Future Forecast

• 12.1 Glucokinase Market Forecast by Regions
  • 12.1.1 Global Glucokinase Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Glucokinase Revenue Forecast by Regions 2019-2025
• 12.2 Glucokinase Market Forecast by Product
  • 12.2.1 Global Glucokinase Sales Forecast by Product 2019-2025
  • 12.2.2 Global Glucokinase Revenue Forecast by Product 2019-2025
• 12.3 Glucokinase Market Forecast by End User
• 12.4 North America Glucokinase Forecast
• 12.5 Europe Glucokinase Forecast
• 12.6 Asia Pacific Glucokinase Forecast
• 12.7 Central & South America Glucokinase Forecast
• 12.8 Middle East and Africa Glucokinase Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Glucokinase Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Glucokinase market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucokinase market based on company, product type, end user and key regions.

This report studies the global market size of Glucokinase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glucokinase in these regions.
This research report categorizes the global Glucokinase market by top players/brands, region, type and end user. This report also studies the global Glucokinase market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp

Market size by Product
LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others
Market size by End User
Metabolic Disorder
Obesity
Diabetes
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Glucokinase market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glucokinase market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glucokinase companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glucokinase submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Glucokinase are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glucokinase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.